Lazard Asset Management LLC Outset Medical, Inc. Transaction History

Lazard Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.94 - $4.61 $105,082 - $249,705	-54,166 Reduced 10.34%	469,694 $1.81 Million
Q1 2024 May 14, 2024	BUY	$1.99 - $5.64 $530,766 - $1.5 Million	266,717 Added 103.72%	523,860 $1.16 Million
Q4 2023 Feb 14, 2024	BUY	$3.07 - $10.25 $112,033 - $374,053	36,493 Added 16.54%	257,143 $1.39 Million
Q3 2023 Nov 14, 2023	BUY	$10.52 - $20.68 $319,250 - $627,575	30,347 Added 15.95%	220,650 $2.4 Million
Q2 2023 Aug 14, 2023	BUY	$17.18 - $23.76 $788,304 - $1.09 Million	45,885 Added 31.77%	190,303 $4.16 Million
Q1 2023 May 15, 2023	BUY	$18.25 - $30.26 $2.57 Million - $4.26 Million	140,915 Added 4022.69%	144,418 $2.66 Million
Q4 2022 Feb 14, 2023	BUY	$12.36 - $26.41 $43,297 - $92,514	3,503 New	3,503 $90,000

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.